Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Stroke. 2014 Nov 25;46(1):229–236. doi: 10.1161/STROKEAHA.114.006982

Table 1.

Physiological parameters.

Experiment Treatment Duration Genotype Drug BP pH pCO2 O2
SD Chronic WT Control 92±7 7.41±0.04 28±4 132±18
WT Topiramate 98±9 7.34±0.03 30±4 140±12
WT Lamotrigine 89±7 7.37±0.04 30±2 113±15
R192Q Control 96±5 7.38±0.04 28±4 132±16
R192Q Topiramate 88±7 7.33±0.04 27±3 142±11
R192Q Lamotrigine 95±8 7.36±0.03 29±2 129±13
Acute WT Control 88±6 7.31±0.04 32±4 134±11
WT Topiramate 81±7 7.25±0.02 34±5 153±5
WT Lamotrigine 82±4 7.33±0.04 34±5 137±16
PID Chronic WT Control 95±16 7.38±0.03 38±5 122±30
WT Topiramate 88±11 7.37±0.05 37±6 131±23
WT Lamotrigine 94±10 7.40±0.05 33±6 136±25
Acute WT Control 92±13 7.40±0.04 36±3 116±13
WT Topiramate 82±11 7.35±0.07 37±6 129±12
WT Lamotrigine 85±10 7.40±0.04 34±6 123±25

Data are displayed as mean ± standard deviation.